1.90
Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
20.03%
0.869
|
0.724 | 0.893 | 0.784 | 0.952 |
| Operating Expenses |
16.45%
1.685
|
1.447 | 2.445 | 1.646 | 1.647 |
| Depreciation and Amortization |
1.06%
0.095
|
0.094 | 0.097 | 0.096 | 0.096 |
| Operating Income/Loss |
12.86%
-0.816
|
-0.723 | -1.552 | -0.862 | -0.695 |
| Nonoperating Income/Loss |
18.64%
0.98
|
0.826 | 0.972 | 0.912 | 1.24 |
| Income/Loss From Continuing Operations Before Tax |
59.22%
0.164
|
0.103 | -0.58 | 0.05 | 0.545 |
| Income/Loss From Continuing Operations After Tax |
59.22%
0.164
|
0.103 | -0.612 | 0.05 | 0.545 |
| Income/Loss From Discontinued Operations, Net Of Tax |
12.50%
-0.009
|
-0.008 | -0.007 | 0.102 | 0.006 |
| Net Income/Loss |
63.16%
0.155
|
0.095 | -0.619 | 0.152 | 0.551 |
| Basic Average Shares |
99,900%
11.57
|
0.0116 | - | 11.57 | 11.57 |
| Diluted Average Shares |
99,926%
11.64
|
0.0116 | - | 11.57 | 11.57 |
| Basic Earnings Per Share |
0.00%
0.01
|
0.01 | - | 0.01 | 0.05 |
| Diluted Earnings Per Share |
0.00%
0.01
|
0.01 | - | 0.01 | 0.05 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):